Salus Scientific successfully closed its Series A financing round, raising $10.1 million, surpassing the initial $8 million target due to strong investor demand. The additional funds will support the company's commercial scale-up, production expansion, and clinical infrastructure development as it ramps up revenue. CEO Todd Flohr highlighted that the oversubscription reflects confidence in Salus's business model and execution. This capital injection positions Salus Scientific to advance its occupational wellness platform for healthcare professionals involved in fluoroscopy-guided procedures.
Netflix currently holds $27 billion in cash and resources earmarked for buying back its own stock, which represents roughly 8% of the company's total shares. This significant buyback capacity indicates Netflix's confidence in its valuation and a stra...
On September 18, 2026, US spot Bitcoin ETFs attracted $433 million in net inflows, while spot Ethereum ETFs gained $144 million, marking a rebound from previous mixed sessions. Fidelity led Bitcoin ETF inflows with $311 million, and BlackRock led Eth...
Bitcoin is moving away from a weakness zone and may enter a stronger bullish phase, according to CryptoQuant's analysis. Although the market has not yet experienced extreme speculative mania, Bitcoin's price rose 2.5% to $78,240.79, with indicators s...
XRP is approaching a significant technical breakout with a daily close above $1.55, completing an inverse head-and-shoulders pattern that signals a potential 35% rally toward $2. This pattern has been developing since summer, with strong buyer suppor...
Prologis, a leading global logistics REIT, shows strong revenue and core FFO growth supported by steady rental income and expanding data center segments. However, its current valuation at a premium 26x AFFO multiple and a modest 3.2% dividend yield l...
